Patient Monitoring Outcome FHIR Implementation Guide, published by My Organization. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-be/patient-monitoring/ and changes regularly. See the Directory of published versions

Antitumoral therapy

DRAFT: 2025-02-07

Care Pathway Overview

The goal of antitumor therapy is the implementation of home hospitalization which increases the efficiency of the oncology day hospital as well as increasing patient and caregiver satisfaction. Patients will be included based on inclusion criteria and their own choice. Specifically, subcutaneous or intramuscular administration will be done at the patient’s home by a home nurse. On the day of administration, the home nurse will visit the patient and record a number of parameters and if they fall within certain limits, the medication will be administered. If one or more parameters are abnormal, the home nurse should first consult with the treating oncologist by telephone whether or not the administration can be done.

Process and Workflow Description

Start-Up

• Parameters Monitored:

  • Heart Rate
  • Blood Pressure
  • Body weight
  • Body temperature
  • Swelling of bilateral feet
  • Orthopneu
  • Injection site pain

Data Collection

• Technology is CE-certified, with end-to-end encryption and GDPR compliance.

Integration Modules for EPD

Outcome Module - FHIR Integration

Vital Signs & symptoms

• Frequency: Ad hoc registrations by patients and healthcare providers.
• LOINC & SNOMED Codes:

General

Specification:

For detailed specifications, refer to the

• Heart Rate Example
• Blood Pressure Example
• Weight Example
• Orthopneu Example